Results for tag: "Flosequinan"

Flosequinan is a cardiovascular drug used to treat congestive heart failure. It is a selective inhibitor of the enzyme phosphodiesterase-3, which is involved in the breakdown of cyclic adenosine monophosphate (cAMP). Flosequinan works by increasing the levels of cAMP, which helps to relax the heart muscle and improve its pumping action. Flosequinan is available in both oral and intravenous formulations. It is usually prescribed in combination with other drugs, such as diuretics and ACE inhibitors, to treat congestive heart failure. Flosequinan is a relatively new drug, and its market is still in its early stages. It is primarily used in the treatment of congestive heart failure, but it is also being studied for its potential use in other cardiovascular conditions. The drug is currently approved in several countries, including the United States, Canada, and the European Union. Some companies in the Flosequinan market include Merck & Co., Inc., Pfizer, Inc., and Novartis AG. Show Less Read more